Where is the grass greener?
Considering both financial services and life science industries typically make it onto the top 10 list of most regulated…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Monthly Archives
August 2018
CMS Proposes Adding More Accountability to ACOs
On August 9, the Centers for Medicare and Medicare Services (CMS) released major changes to Accountable Care Organizations (ACOs).…
HHS OIG Performs Review of Open Payments Data – 99.9% of 2015 Data…
Recently, the United States Department of Health and Human Services Office of Inspector General (HHS OIG) completed a review of…
FDA Hits Baxter with Warning Letter Over Claris Acquisition
Almost one year to the day Baxter acquired Claris Injectables, the United States Food and Drug Administration (FDA) sent a warning…
FDA Announces Two New Quality Metrics Programs
Earlier this year, the U.S. Food and Drug Administration (FDA) announced two new voluntary quality programs — the Quality Metrics…
Medicare Part D Premiums Continue to Decline
On July 31, 2018, the United States Centers for Medicare & Medicaid Services announced that for the second year in a row, the…
Are Doctors Really Influenced by the Pharmaceutical Industry?
Recently, Rafael Fonseca, MD and John A. Tucker, MBA, PhD, issued a critical analysis of a recent study that drew correlations…
MEDX Rockpointe Primary Care 2018 Conferences feature 3 hours of education…
In an effort to fight the opioid crisis and to help physicians and other health care providers meet state CME requirements for…
CMS Reviewing National Coverage Determination for TAVR Programs
Recently, the United States Center for Medicare & Medicaid Services (CMS) announced a review of its national coverage…
Price Transparency: It’s Not Just Pharma…
Price transparency has been a “buzz phrase” for the pharmaceutical industry for the last several years. However, the state of New…